CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Therapeutic Cancer Vaccines: Targeting the Future of Cancer Treatment CME
Chairperson: Mary L. Disis, MD; Faculty: Michael A. Morse, MD; Jeffrey S. Weber, MD, PhD
Disclosures

Release Date: September 5, 2002; Valid for credit through September 5, 2003

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


Editorial Content produced by IntraMed Educational GroupThis CME activity, "Therapeutic Cancer Vaccines: Targeting the Future of Cancer Treatment," was originally offered as a slide program certified for CME.

Contents of This CME Activity
  1. Introduction and Overview
    The Players in the Immune System
    Immunity and Antigen Recognition
    Cancer and the Immune System
    Human Tumors and Immunogenicity
    Strategies for Vaccine Development

  2. Tumor-Antigen Vaccines for Cancer
    Approaches to Cancer Vaccines and Immune Monitoring
    Assays for Immune Monitoring
    Tumor Antigens and Antigen-Specific Vaccines
    Tumor Antigens
    Gangliosides
    Carbohydrate-Based Approaches
    Peptide Vaccines
    A Look at Peptides in Cancer
    Understanding Vaccines in Cancer

  3. Current Status of Dendritic-Cell Vaccines
    Dendritic Cells, Tumor Antigens, and Immune Responses
    Dendritic Cells and Vaccine Development
    Antigen-Loading Strategies With Dendritic Cells
    Mature vs Immature Dendritic Cells
    Distribution of Dendritic Cells and Boosting the Immune Response
    The Dendritic Cell Vaccine
    Dendritic Cell Vaccines: Conclusions

  4. Cellular Vaccines for Cancer
    Cellular Vaccines: Background
    Melacine Vaccine
    Southwest Oncology Group Study of the Melacine Vaccine
    The CancerVax Vaccine
    The Oncolysate Vaccine
    Conclusions on Cellular Vaccine Therapy
    Cell Vaccine for Colon Cancer
    Cytokine Secretion Boosts Cell Immunity

  5. Current Status of DNA and Viral Vector Vaccines for Cancer Immunotherapy
    Genetic Vaccination for Cancer Immunotherapy
    Vector Platforms: Plasmids and Adenovirus
    Vector Platforms: Orthopox Viruses
    Inducing the Immune Response
    Increasing Immunogenicity
    Clinical Trials of Genetic Vaccines
    Viral Vaccines: Summary

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, the CME provider, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2002 IntraMed Educational Group
EMD
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.